(813) 345-4044 1767 S. Kings Ave., Brandon, FL
(813) 345-4044 | info@floridaaesthetics.com | Mon–Tue & Thu–Fri: 8am–5pm  ·  Wed: 10am–7pm | 1767 S. Kings Ave., Brandon, FL 33511
GLP-1 weight loss medications at Florida Aesthetics and Wellness Brandon FL

Weight Loss · GLP-1 Therapy · Brandon, FL

GLP-1 Medications
for Weight Loss

GLP-1 receptor agonists are the most effective medical weight loss tools available today. Here is how they work, the options we offer, and who they are right for, all under medical supervision.

Book a Free Consultation Call (813) 345-4044
Up to 21%
body weight reduction (tirzepatide)
2 Options
Semaglutide & Tirzepatide
Supervised
since 2006
The Medication Class

What are GLP-1 medications, and how do they work?

Reviewed by our board-certified anti-aging specialists. Medically supervised since 2006.

GLP-1 receptor agonists are a class of injectable medications that treat overweight and obesity by working with your body's own appetite-regulating hormones, not stimulants or willpower.

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after eating. GLP-1 medications mimic it, activating receptors in the brain that control hunger and fullness. The result is a meaningful drop in appetite, less food "noise," slower gastric emptying, and steadier blood sugar. Originally developed for type 2 diabetes, this class is now a cornerstone of medical weight loss. Tirzepatide goes a step further as a dual agonist, activating both the GIP and GLP-1 receptors. At Florida Aesthetics and Wellness, every GLP-1 program is medically supervised, with gradual dose titration and weekly in-clinic check-ins.

The GLP-1 medications we offer

  • Semaglutide: single GLP-1 agonist, about 15% average body weight reduction in trials
  • Tirzepatide: dual GIP/GLP-1 agonist, up to about 21% in trials

Who qualifies for GLP-1 therapy?

  • Obesity (BMI ≥30)
  • Overweight (BMI ≥27 with a weight-related condition)
  • Insulin resistance, pre-diabetes, or metabolic syndrome
  • Weight regain after previous weight loss
  • Diet-resistant weight despite real effort

Quick Facts

  • ClassGLP-1 receptor agonists
  • OptionsSemaglutide, Tirzepatide
  • AdministrationWeekly subcutaneous injection
  • Average weight loss15% to 21% in trials
  • MonitoringWeekly check-ins
  • ConsultationRequired before prescribing
Medically supervised GLP-1 weight loss program at Florida Aesthetics and Wellness Brandon FL
How It Works

How a medically supervised GLP-1 program works

1
Medical evaluation
Your provider reviews your health history, current medications, and goals to screen for contraindications and establish your baseline.
2
Choosing your medication
Together you decide between semaglutide and tirzepatide based on your goals, medical history, and what your insurance or budget supports.
3
Titration phase
You start low and increase gradually every few weeks toward your therapeutic dose. This minimizes nausea and GI side effects while appetite and cravings steadily decline.
4
Maintenance and monitoring
Weekly in-clinic check-ins track progress, adjust dosing, and support nutrition and lifestyle so your results last.
Common Questions

GLP-1 Medications, Frequently Asked Questions

GLP-1 receptor agonists are injectable medications that treat overweight and obesity by working with your body's appetite-regulating hormones. They reduce hunger, slow gastric emptying, and improve blood sugar control. Semaglutide and tirzepatide are the two we offer.
Semaglutide activates one receptor (GLP-1) and produces about 15% average body weight reduction in trials. Tirzepatide is a dual agonist that activates both GIP and GLP-1 and has shown up to about 21%. See the full comparison.
GLP-1 therapy is generally appropriate for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or insulin resistance. A medical evaluation determines whether it is right and safe for you.
When prescribed after a medical evaluation, sourced from a licensed pharmacy, and monitored by a provider, GLP-1 medications have a well-established safety profile. The real risk comes from black-market products. Read about safe sourcing.
Weight regain is common after stopping GLP-1 medications. Many patients continue long term or transition to a maintenance dose. We build a long-term plan with you rather than leaving you to figure it out alone.
Most patients come in weekly. The visit is both your injection and your check-in, so your dose, your progress, and any side effects are reviewed in person as you go. Patients who prefer to self-inject at home can be approved for that by our board-certified anti-aging specialist and come in monthly instead. In both cases your dosing and titration are approved by your provider, not set automatically.
Explore the Options

Your GLP-1 weight loss options

Compare the medications, understand the safety story, and find the right fit with your provider.

Aesthetics

Noticing Facial Changes?

Rapid weight loss can deflate the face and loosen skin. See how we restore volume and firmness naturally.

Restore your look →
Weight Loss

Semaglutide

The single GLP-1 agonist with about 15% average body weight reduction, weekly and medically supervised.

Explore semaglutide →
Weight Loss

Tirzepatide

The dual GIP/GLP-1 agonist showing up to 21% weight loss, for patients seeking maximum results.

Explore tirzepatide →
Compare

Semaglutide vs Tirzepatide

A side-by-side look at results, dosing, side effects, and cost to help you and your provider choose.

Compare them →
Safety

GLP-1 Safety & Sourcing

Where compounded GLP-1 comes from, how we source it, and how to avoid dangerous black-market products.

Explore GLP-1 safety →

Curious about cost? Your cost depends on the option that fits your case, which we map out at your consultation. The treatment you’re interested in might be on sale this month, so see our pricing page for current rates and check this month’s specials.

See weight loss program costs This Month’s Specials

This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider about your specific situation.

Clinical References

  1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Mean body weight change of −14.9% at week 68 (STEP 1).
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Mean body weight reduction of 15.0%, 19.5% and 20.9% at 72 weeks for the 5 mg, 10 mg and 15 mg doses (SURMOUNT-1).

Trial results reflect study populations under clinical supervision alongside lifestyle intervention. Individual results vary.

Ready to Start?

Start with a complimentary consultation, no obligation

A medical provider will evaluate your health history and help you decide whether semaglutide or tirzepatide is the right fit. Schedule your complimentary consultation.

Book a Free Consultation See This Month's Specials Call (813) 345-4044